GRACE Targeted Therapies Lung Cancer 2021 - ROS1 & ALK Tr...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.
For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda , and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty.
In this video, from the ALK/ROS1 breakout session, Drs. Jessica Lin and Chul Kim discuss what treatment options are available for ROS1 and ALK cancer that transforms to a neuroendocrine tumor.
A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda , and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty.
In this video, from the ALK/ROS1 breakout session, Drs. Jessica Lin and Chul Kim discuss what treatment options are available for ROS1 and ALK cancer that transforms to a neuroendocrine tumor.
A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Lung
描述
Lung Cancer
![ASCO [2022] Lung Cancer In-Depth Slides: MOASC](https://oncologytubecom.cdn.ypt.me/videos/video_220921124802_v9213/video_220921124802_v9213_thumbsV2_jpg.webp?cache=1670440672_1670440672 "ASCO [2022] Lung Cancer In-Depth Slides: MOASC")
